Diamox and Transverse sinus thrombosis - a phase IV clinical study of FDA data

Summary:

Transverse sinus thrombosis is reported as a side effect among people who take Diamox (acetazolamide), especially for people who are female, 20-29 old, also take Yasmin, and have Nausea.

The phase IV clinical study analyzes which people have Transverse sinus thrombosis when taking Diamox. It is created by eHealthMe based on reports of 4,260 people who have side effects when taking Diamox from the FDA, and is updated regularly.

What is Diamox?

Diamox has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 4,711 Diamox users. Check the latest studies of Diamox.

What is Transverse sinus thrombosis?

Transverse sinus thrombosis (a blood clot in transverse sinus) is found to be associated with 119 drugs and 268 conditions by eHealthMe. Check the latest studies of Transverse sinus thrombosis.

On Jul, 30, 2026

4,260 people reported to have side effects when taking Diamox.
Among them, 12 people (0.28%) have Transverse sinus thrombosis.

Could Diamox cause Transverse sinus thrombosis?

Among these 12 people:

What is the gender of people who have Transverse sinus thrombosis when taking Diamox? *

female: 100 %
male: 0.0 %

What is the age of people who have Transverse sinus thrombosis when taking Diamox? *

What are other drugs people take besides Diamox? *

Yasmin: 7 people, 58.33%
Prednisone: 6 people, 50.00%
Compazine: 5 people, 41.67%
Zofran: 4 people, 33.33%
Vicodin: 4 people, 33.33%
Yaz: 4 people, 33.33%
Drospirenone And Ethinyl Estradiol: 3 people, 25.00%
Dexamethasone: 3 people, 25.00%
Toradol: 3 people, 25.00%
Ibuprofen: 3 people, 25.00%

What are other side effects people have besides Transverse sinus thrombosis? *

Superior Sagittal Sinus Thrombosis (blood clot in the dural venous sinuses, which drain blood from the brain): 9 people, 75.00%
Jugular Vein Thrombosis (clot in jugular vein): 6 people, 50.00%
Headache (pain in head): 5 people, 41.67%
Pain: 4 people, 33.33%
Intracranial Venous Sinus Thrombosis (presence of thrombosis (a blood clot) in the dural venous sinuses, which drain blood from the brain): 4 people, 33.33%
Emotional Distress: 3 people, 25.00%
Stress And Anxiety: 3 people, 25.00%
Sinus Headache (headache caused by sinus infections): 3 people, 25.00%
Scotoma (an area of diminished vision within the visual field): 3 people, 25.00%
Intracranial Pressure Increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid): 3 people, 25.00%

What are the existing conditions these people have? *

Pain: 4 people, 33.33%
Nausea (feeling of having an urge to vomit): 4 people, 33.33%
Sinus Disorder (disease of sinus): 3 people, 25.00%
Migraine (headache): 3 people, 25.00%
Headache (pain in head): 3 people, 25.00%
Nausea And Vomiting: 2 people, 16.67%
Menstruation Irregular: 2 people, 16.67%
Behcet's Syndrome (involves inflammation of the blood vessels): 2 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Papilloedema (optic disc swelling): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Diamox and have Transverse sinus thrombosis?

- Check whether Transverse sinus thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diamox:

Diamox (4,711 reports)

Browse all side effects of Diamox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Transverse sinus thrombosis:

Transverse sinus thrombosis (119 drugs)

Browse all the conditions that are associated with Transverse sinus thrombosis:

Transverse sinus thrombosis (268 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide (the active ingredients of Diamox) and Diamox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.